Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Sep 11;12(1):444.
doi: 10.1186/s13071-019-3685-3.

Preventive efficacy of oral moxidectin at various doses and dosage regimens against macrocyclic lactone-resistant heartworm (Dirofilaria immitis) strains in dogs

Tom L McTier  1 , Robert H Six  2 , Aleah Pullins  2 , Sara Chapin  2 , Kristina Kryda  2 , Sean P Mahabir  2 , Debra J Woods  2 , Steven J Maeder  2
Affiliations

Preventive efficacy of oral moxidectin at various doses and dosage regimens against macrocyclic lactone-resistant heartworm (Dirofilaria immitis) strains in dogs

Tom L McTier et al. Parasit Vectors. .

Abstract

Background: Moxidectin has previously shown limited efficacy (≤ 44.4%) against confirmed macrocyclic lactone (ML)-resistant Dirofilaria immitis strains at 3 µg/kg after single and multiple oral dosages. Three studies were conducted to evaluate higher oral moxidectin doses for efficacy against confirmed ML-resistant D. immitis strains.

Methods: Dogs were inoculated with 50 D. immitis L3 and randomly allocated to treatments. Study 1: 6 groups of dogs (n = 8) were inoculated with JYD-34 (Day - 30) and treated as follows: T01, negative control; T02-T05, moxidectin at 3, 6, 12 or 24 µg/kg, respectively, on Day 0 only; T06, moxidectin at 3 µg/kg on Days 0, 30 and 60. Study 2: 10 groups of dogs (n = 5) were inoculated (Day - 30) with either JYD-34 (T01, T03-05) or ZoeLA (T02, T06-T10) and treated as follows: T01 and T02, negative controls; T03-T05, moxidectin at 24, 40 or 60 µg/kg, respectively, on Days 0, 28 and 56; T06 and T09, moxidectin at 3 or 60 µg/kg on Day 0 only; T07, T08 and T10, moxidectin at 24, 40 or 60 µg/kg, respectively, on Days 0, 28 and 56. Study 3: 5 groups of dogs (n = 5) were inoculated with ZoeMO (Day - 28) and treated as follows: T01, negative control; T02, moxidectin at 3 µg/kg moxidectin on Day 0 only; T03-T05, moxidectin at 24, 40 or 60 µg/kg, respectively, on Days 0, 28 and 56. All dogs were necropsied for adult heartworm recovery ~ 4-5 months post-inoculation.

Results: All moxidectin-treated dogs showed significantly lower worm counts than controls. The efficacy of moxidectin administered once at 3 µg/kg was 19% (JYD-34), 44.4% (ZoeLA) and 82.1% (ZoeMO). Increasing both the dose and the number of dosages of moxidectin improved efficacy, with 100% protection obtained using three dosages of moxidectin at either 40 µg/kg (JYD-34, ZoeMO) or 60 µg/kg (ZoeLA). Three dosages of 24 µg/kg were also highly effective, providing ≥ 98.8% efficacy for all three strains.

Conclusions: Increasing both the dose and number of consecutive monthly dosages of moxidectin improved the efficacy against ML-resistant heartworms. Based on these data and other technical considerations, the 24 µg/kg dose was considered the optimal dose for further commercial development.

Keywords: Canine; Dirofilaria immitis; Heartworm; Macrocyclic lactone; Moxidectin; Resistance.

PubMed Disclaimer

Conflict of interest statement

TLM, AP, SC, KK, SPM, DW and SM are current employees of Zoetis. RS is a former employee of Zoetis.

References

    1. Arther RG, Bowman DD, Slone RL, Travis LE. Imidacloprid plus moxidectin topical solution for the prevention of heartworm disease (Dirofiloria immitis) in dogs. Parasitol Res. 2005;97(Suppl. 1):S76–S80. doi: 10.1007/s00436-005-1448-x. - DOI - PubMed
    1. Bowman DD, Grazette AR, Basel C, Wang Y, Hostetler JA. Protection of dogs against canine heartworm infection 28 days after four monthly treatments with Advantage Multi® for Dogs. Parasit Vectors. 2016;9:12. doi: 10.1186/s13071-016-1293-z. - DOI - PMC - PubMed
    1. Bowman DD, Ohmes CM, Hostetler JA, Keil DJ, Settje TL, Charles SD. Efficacy of 10% imidacloprid + 2.5% moxidectin topical solution (Advantage Multi® for Dogs) for the prevention of heartworm disease and infection all month long. Parasit Vectors. 2017;10(Suppl. 2):478. doi: 10.1186/s13071-017-2432-x. - DOI - PMC - PubMed
    1. Lok JB, Knight DH, McCall JW, Dzimianski MT, Cleale RM, Wang GT, et al. Recent advances in heartworm disease-symposium ʼ01. Batavia: American Heartworm Society; 2001. Six-month prophylactic efficacy of an injectable, sustained-release formulation of moxidectin against Dirofilaria immitis infection: a two-center study; pp. 149–157.
    1. Lok JB, Knight DH, Wang GT, Doscher ME, Nolan TJ, Hendrick MJ, et al. Activity of an injectable, sustained-release formulation of moxidectin administered prophylactically to mixed-breed dogs to prevent infection with Dirofilaria immitis. Am J Vet Res. 2001;62:1721–1726. doi: 10.2460/ajvr.2001.62.1721. - DOI - PubMed

MeSH terms